Society guideline links: Chronic myeloid leukemia

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Myeloproliferative neoplasms" and "Society guideline links: Myelodysplastic syndromes" and "Society guideline links: Acute myeloid leukemia".)

International

●European Society of Cardiology (ESC) and International Cardio‐Oncology Society (IC-OS): A position statement and new risk assessment tools on baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies (2020)

●World Health Organization (WHO): Classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition (2017)

●International BFM Group (iBFM): Managing children with chronic myeloid leukaemia (CML) – Recommendations for the management of CML in children and young people up to the age of 18 years (2014)

Europe

●European LeukemiaNet (ELN): Recommendations for treating chronic myeloid leukemia (2020)

●European Society of Cardiology (ESC) and International Cardio‐Oncology Society (IC-OS): A position statement and new risk assessment tools on baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies (2020)

●European Society for Medical Oncology (ESMO): Chronic myeloid leukaemia – Clinical practice guidelines for diagnosis, treatment, and follow-up (2017)

●Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel (2017)

United Kingdom

●British Society for Haematology (BSH): A guideline on the diagnosis and management of chronic myeloid leukaemia (2020)

●Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK (2018)

Japan

●Japanese Society of Hematology (JSH): Guideline for tumors of hematopoietic and lymphoid tissues – Leukemia: Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN) (2017)